We believe that Epigenomics AG, or Epigenomics, is our main competitor in the blood-based diagnostic market. Epigenomics’ methylated DNA-based PCR, test in colon cancer (Epi proColon\u00ae) is available in the United States, Europe, China and select other countries and its lung cancer test (Epi proLung\u00ae) has been CE-Marked in Europe. https://www.sec.gov/Archives/edgar/data/93314/00010787821900… |
|
aus der Diskussion: | EPIGENOMICS N Helden |
Autor (Datum des Eintrages): | Amanitamuscaria (14.03.19 11:48:08) |
Beitrag: | 42,139 von 52,366 (ID:60098283) |
Alle Angaben ohne Gewähr © wallstreetONLINE |